Search

everythinglearnresearchcommunity

for

Search:↓

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Low iron levels are linked to hair loss in women.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Treat hair loss with medicine, continue indefinitely.

Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.